January
Endo testosterone gel approved
The US Food and Drug Administration has approved Endo Pharmaceuticals' Fortesta testosterone gel as a treatment for men with hypogonadism
04 Jan 2011
Centocor seeks new use for Remicade
Centocor Ortho Biotech has filed a supplemental application with the US Food and Drug Administration to expand the approved indications of Remicade
04 Jan 2011
Cephalon jet lag application rejected
Cephalon has dropped its bid to get sleep disorder drug Nuvigil approved as a treatment for jet lag after a second rejection from the US FDA
04 Jan 2011
Cystic fibrosis drug disappoints in trial
Shares of Inspire Pharma have fallen by 58 per cent after its cystic fibrosis drug denufosol tetrasodium failed to meet expectations in a phase III trial
04 Jan 2011
GSK responds to suggestions of patient harm
GSK has issued a response to the 60 Minutes TV programme aired in the US that focused on a former manufacturing facility in Puerto Rico
04 Jan 2011
Dr Véronique Walsh joins BMS UK
Bristol-Myers Squibb UK has appointed Dr Véronique Walsh to the role of business unit director, neuroscience and immunoscience
05 Jan 2011
Stroke drug submitted for EU/US approval
Rivaroxaban has been submitted for marketing approval in the EU by Bayer and the US by J&J for the prevention of stroke in patients with AF
05 Jan 2011
New medical animation company launched
Fusion Medical Animation, a new company specialising in drug mode of action (MOA) animation has been founded by Simon Reid, the former director of production at Random42
05 Jan 2011
Pfizer expands RNA development deal
Pfizer has signed a development and commercialisation deal potentially worth more than $600m with the Danish firm Santaris Pharma
05 Jan 2011
FDA grants orphan status for two drugs
Senesco has won US orphan drug status for a multiple myeloma drug, while Optimer has won orphan status for a potential drug for paediatric CDI
05 Jan 2011